|
“Identifying Cancer Patients at High Risk for ER Visits and Hospitalizations: The Supportive Oncology Screener” and “Acute Promyelocytic Leukemia: Induction Therapy for the High Risk Patient” |
10/16/2017 - 12:00pm to 1:00pm |
|
“Hypomethylating Agents in AML: Understanding Practice Patterns and Enhancing Therapeutic Benefit” and “Immune Related Adverse Events: When to Refer” |
10/09/2017 - 12:00pm to 1:00pm |
|
“Enhancing the Immune Response in Non-Small Cell Lung Cancer” and “Targeting Cellular Metabolism Through Modulation of BACH1 in Triple Negative Breast Cancer ” |
10/02/2017 - 12:00pm to 1:00pm |
|
“Chronic Lymphocytic Leukemia The Role of Ibrutinib in the First-Line Setting” and “Promise and Perils of Precision Medicine in Diffuse Large B-Cell Lymphoma” |
09/18/2017 - 12:00pm to 1:00pm |
|
“Hepatocellular Carcinoma: Treatment Challenges and the Landscape of Investigational Therapeutics” |
09/11/2017 - 12:00pm to 1:00pm |
|
“Development of the Glucocorticoid Receptor As A Novel Therapeutic Target in Prostate Cancer” |
08/28/2017 - 12:00pm to 1:00pm |
|
“DNA Repair Defects in Metastatic Castrate Resistant Prostate Cancer” and “Making the Most in Graft-vs-Host: Biomarkers & Novel Treatment Strategies for GVHD” |
08/21/2017 - 12:00pm to 1:00pm |
|
"Therapeutic Strategies to Enhance Immune-Responsiveness in PTEN-deficient Cancers" |
08/14/2017 - 12:00pm to 1:00pm |
|
Cutaneous T-cell Lymphoma: Mycosis Fungoides and Sezary Syndrome |
08/07/2017 - 12:00pm to 1:00pm |
|
Management of resectable Esophagogastric and gastric cardia adenocarcinoma |
07/31/2017 - 12:00pm to 1:00pm |
Facebook
Twitter
LinkedIn
Forward